Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: A p53 Research Group study
2015 ◽
Vol 41
(5)
◽
pp. 683-689
◽
Keyword(s):
Keyword(s):
Keyword(s):
2016 ◽
Vol 24
(1)
◽
pp. 236-243
◽
Keyword(s):
2007 ◽
Vol 33
(9)
◽
pp. 1106-1106
2018 ◽
Vol 44
(7)
◽
pp. 1069-1077
◽